Breast Cancer Research and Treatment
Papers 9420
1 page of 942 pages (9,420 results)
Published on Jul 13, 2019in Breast Cancer Research and Treatment3.47
Susan K. Boolbol15
Estimated H-index: 15
(Beth Israel Medical Center),
Manju Harshan (Lenox Hill Hospital)+ 8 AuthorsFrederick L. Baehner31
Estimated H-index: 31
Purpose Adjuvant therapy decisions may in part be based on results of Oncotype DX Breast Recurrence Score® (RS) testing of primary tumors. When necessary, lymph node metastases may be considered as a surrogate. Here we evaluate the concordance in gene expression between primary breast cancers and synchronous lymph node metastases, based on results from quantitative RT-PCR-based RS testing between matched primary tumors and synchronous nodal metastases.
Published on Jul 17, 2019in Breast Cancer Research and Treatment3.47
José María Huerta48
Estimated H-index: 48
Antonio J. Molina15
Estimated H-index: 15
(University of León)
+ 16 AuthorsFrancisco Javier Llorca Martinez39
Estimated H-index: 39
(UC: University of Cantabria)
Purpose Literature on the separate effects of physical activities (PA) on risk of breast cancer (BC) sub-types is heterogeneous. We investigated domain-specific associations between PA and BC risk by menopausal status and molecular subtype.
Published on Jul 12, 2019in Breast Cancer Research and Treatment3.47
Edoardo Isnaldi2
Estimated H-index: 2
(UniGe: University of Genoa),
Domenico Ferraioli3
Estimated H-index: 3
(UniGe: University of Genoa)
+ 6 AuthorsGabriele Zoppoli18
Estimated H-index: 18
(UniGe: University of Genoa)
Published on Jul 17, 2019in Breast Cancer Research and Treatment3.47
Rong Tang11
Estimated H-index: 11
(Harvard University),
Francisco Acevedo4
Estimated H-index: 4
(Harvard University)
+ 12 AuthorsCurtis L. Cetrulo30
Estimated H-index: 30
(Harvard University)
Introduction Bilateral reduction mammoplasty is one of the most common plastic surgery procedures performed in the U.S. This study examines the incidence, management, and prognosis of incidental breast cancer identified in reduction specimens from a large cohort of reduction mammoplasty patients.
Published on Jul 13, 2019in Breast Cancer Research and Treatment3.47
Bernadette A. M. Heemskerk-Gerritsen5
Estimated H-index: 5
(EUR: Erasmus University Rotterdam),
Agnes Jager24
Estimated H-index: 24
(EUR: Erasmus University Rotterdam)
+ 15 AuthorsJ. de Vries54
Estimated H-index: 54
(UMCG: University Medical Center Groningen)
Background In healthy BRCA1/2 mutation carriers, bilateral risk-reducing mastectomy (BRRM) strongly reduces the risk of developing breast cancer (BC); however, no clear survival benefit of BRRM over BC surveillance has been reported yet.
Published on Jun 28, 2019in Breast Cancer Research and Treatment3.47
Antonio Ponti24
Estimated H-index: 24
Guglielmo Ronco38
Estimated H-index: 38
+ 12 AuthorsPatricia Fitzpatrick22
Estimated H-index: 22
Purpose Nuclear grade is an important indicator of the biological behaviour of ductal carcinoma in situ (DCIS). De-escalation of treatment has been suggested for low-grade DCIS. Our aim is to estimate the relative rate of progression of DCIS by nuclear grade by analysing the distribution of nuclear grade by detection at initial or subsequent screening.
Published on Jul 2, 2019in Breast Cancer Research and Treatment3.47
Shinsuke Sasada7
Estimated H-index: 7
(Hiroshima University),
Noriyuki Shiroma3
Estimated H-index: 3
(Hiroshima University)
+ 6 AuthorsMorihito Okada42
Estimated H-index: 42
(Hiroshima University)
Purpose 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) is related to the biological parameters and prognosis of breast cancer. However, whether whole-body PET (WBPET) and dedicated breast PET (DbPET) can reflect the tumor microenvironment is unclear. This study investigated the relationship between stromal tumor-infiltrating lymphocytes (TILs) and maximum standardized uptake value (SUVmax) in WBPET and DbPET.
Published on Jul 1, 2019in Breast Cancer Research and Treatment3.47
Samantha Puvanesarajah (ACS: American Cancer Society), Susan M. Gapstur60
Estimated H-index: 60
(ACS: American Cancer Society)
+ 5 AuthorsMia M. Gaudet33
Estimated H-index: 33
(ACS: American Cancer Society)
Purpose In a screened population, breast cancer-specific mortality is lower for screen-detected versus symptom-detected breast cancers; however, it is unclear whether this association varies by follow-up time and/or tumor characteristics. To further understand the prognostic utility of mode of detection, we examined its association with breast cancer-specific mortality, overall and by follow-up time, estrogen receptor status, tumor size, and grade.
Published on Jun 14, 2019in Breast Cancer Research and Treatment3.47
Lj Fallowfiled79
Estimated H-index: 79
(BSMS: Brighton and Sussex Medical School),
Ivonne Solis-Trapala13
Estimated H-index: 13
(Keele University)
+ 3 AuthorsValerie Jenkins37
Estimated H-index: 37
(BSMS: Brighton and Sussex Medical School)
Purpose Gene expression profiling (GEP) test scores calculate risks of recurrence and likely benefit of adjuvant chemotherapy in ER-positive, HER2-negative, early-stage breast cancer. As health literacy and numeracy skills in the general population are poor, healthcare professionals (HCPs) require a wide repertoire of communication skills to explain clearly risk of recurrence scores (RSs) and uncertainty. We developed and evaluated an educational program for HCPs discussing GEP test results and ...
Published on Jul 11, 2019in Breast Cancer Research and Treatment3.47
Helen M. Johnson1
Estimated H-index: 1
(ECU: East Carolina University),
William Irish43
Estimated H-index: 43
(ECU: East Carolina University)
+ 2 AuthorsJan H. Wong11
Estimated H-index: 11
(ECU: East Carolina University)
Purpose The relationship between age at diagnosis and breast cancer-specific mortality (BCSM) is unclear. The aim of this study was to examine the nature of this relationship using rigorous statistical methodology.